Yahoo Web Search

Search results

    • FDA Gives Nod to RSV Vaccine for People in Their 50s

      US News & World Report· 5 days ago

      The U.S. Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their 50s who are at increased risk for the ...

    • Insurers, providers weigh GLP-1 demand at AHIP 2024

      Modern Healthcare· 2 days ago

      The onus should be on providers — not insurers — to determine which patients may access glucagon-like peptide agnostics, or GLP-1s, Highmark Chief Medical Officer Dr. Timothy ...